NASDAQ
04.03.25
22:00 Uhr
0,095 US-Dollar
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025 | 1 | Insider Monkey | ||
| 13.03. | Zomedica Corp.: Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth | 311 | ACCESS Newswire | ANN ARBOR, MI / ACCESS Newswire / March 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 13.03. | Zomedica Corp. - 10-K, Annual Report | 3 | SEC Filings | ||
| 13.03. | NSE - Zomedica Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 3 | SEC Filings | ||
| 05.03. | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.03. | Zomedica Corp. Announces Transition to OTCQB Venture Market | 390 | ACCESS Newswire | Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company... ► Artikel lesen | |
| 04.03. | NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM) | 100 | Business Wire | NEW YORK--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares... ► Artikel lesen | |
| 26.02. | Zomedica Corp.: Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET | 276 | ACCESS Newswire | ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic... ► Artikel lesen | |
| 12.02. | Zomedica Corp.: Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters | 286 | ACCESS Newswire | Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica"... ► Artikel lesen | |
| 06.02. | Zomedica Corp.: Zomedica Launches the TRUFORMA Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis | 339 | ACCESS Newswire | Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM)... ► Artikel lesen | |
| 07.01. | Zomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health Market | 591 | ACCESS Newswire | License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")... ► Artikel lesen | |
| 23.12.24 | Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health | 10 | Benzinga.com | ||
| 23.12.24 | Zomedica Corp.: Zomedica Launches Two New Quantitative Assays on the TRUFORMA Platform: Canine NT-proBNP and Progesterone | 297 | ACCESS Newswire | With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomedica... ► Artikel lesen | |
| 19.12.24 | Zomedica Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.12.24 | Zomedica appoints Scott Jordan as EVP, finance & CFO | 5 | Seeking Alpha | ||
| 19.12.24 | Zomedica Corp.: Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer | 388 | ACCESS Newswire | Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary... ► Artikel lesen | |
| 27.11.24 | Zomedica Corp.: Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 | 271 | ACCESS Newswire | ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products... ► Artikel lesen | |
| 19.11.24 | Zomedica Corp. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.24 | Zomedica Corp.: Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA Platform | 327 | ACCESS Newswire | Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica"... ► Artikel lesen | |
| 12.11.24 | Zomedica Corp.: Noble Capital Markets Initiates Equity Research Coverage on Zomedica | 306 | ACCESS Newswire | ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
ZOMEDICA CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,095 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.
